MOORESTOWN, N.J., Oct. 16, 2018 — Tabula Rasa HealthCare (NASDAQ: TRHC), President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA received the CEO Report “Mid-Atlantic Women’s Leadership Award” at a gala ceremony held October 10, 2018 in Philadelphia, PA. In 2009, Ms. Knowlton co-founded TRHC, a healthcare technology company advancing the field of medication safety.
CEO Report’s Women’s Leadership Award “honors CEOs and executives who are moving their companies and communities forward. The women selected are trailblazers in business and truly stand out for being passionate about philanthropy and inspiring up and coming leaders.” Winners are selected based on criteria including their companies’ growth and dedication to giving back to the community.
Since the Company’s founding, Dr. Knowlton and the TRHC team now serve over 25% of the PACE market (Programs of All-inclusive Care for the Elderly) and provide interventions for high-risk individual members of Part D plans representing approximately 15% of the total number of Medicare lives.
Active in her community, Dr. Knowlton serves as Trustee, Executive Committee Secretary, and Chair of the Governance Committee for Samaritan Healthcare and Hospice, Marlton, NJ. She is in her 10th year of service at Samaritan, and has been on numerous other non-for-profit boards as trustee or advisor, including as a charter member of the Impact 100 South Jersey Community Foundation.
Having spent her career moving innovation into practice, Dr. Knowlton’s recent publications which she co-authored include: “Implementation of a Pharmacist-led Pharmacogenomics Service for the Program of All-Inclusive Care for the Elderly” and, “Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care”.
Dr. Knowlton is a Fellow of the College of Physicians of Philadelphia and a member of the American Pharmacists Association, American Society of Consultant Pharmacists, Women Business Leaders of the Healthcare Industry Foundation and WomenCorporateDirectors.
Dr. Knowlton received her Bachelor of Science in Pharmacy and Doctorate in Pharmacy from the University of the Sciences School of Pharmacy. She is a graduate of Temple University’s Fox School of Business Executive MBA program.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date including statements regarding risk stratification under the new scope of work. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.